Cybin’s Sublingual Psilocybin Strips Head to Clinical Trials for Dose-Finding
The first trial will determine the sublingual dose equivalent to 25 mg psilocybin administered orally.
Articles - Page 19
MindMed and Liechti Lab to Conduct the First Clinical Trial Combining LSD and MDMA
Researchers will examine whether MDMA can offset some of the negative side effects of LSD in a therapeutic setting.
The Mechanisms of Change in Psychedelic Assisted Psychotherapy
A new study sheds light on cognitive behavioral change mechanisms underlying psychedelic assisted psychotherapy.
Cultivating P. cubensis: Light and Tryptamine Are Key for Controlling Psilocybin and Psilocin Levels
No light and increasing tryptamine in the growing medium leads to more psilocin but less psilocybin in the mushrooms.
Risky Sex and the Recreational Use of MDMA
MDMA is associated with feelings of positivity but does it also increase risky sex behavior?
This is Your Brain on Ego Death
Scientists power down the ego and peek inside the brain, focusing on glutamate activity.
The Role of the Claustrum in the Psychedelic Experience
Brain scans show that psilocybin modulates claustrum connectivity in brain networks.
The Mystical Experience is Critical for the Therapeutic Effects of Psilocybin
Two studies indicate that higher doses of psilocybin are necessary for sustained reductions in depression and anxiety.
Metabolizing DMT – The Differences Between Oral Administration and Smoking
Research is indicating that a less efficient metabolic pathway plays a role in DMT’s psychoactivity.
Beneficial Synergy: Teaming Psilocybin with Mindfulness Meditation
A double-blind study reveals that mindfulness meditation practice may amplify the positive effects of psilocybin while reducing the likelihood of a bad trip.